Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

426

Participants

Timeline

Start Date

August 15, 2016

Primary Completion Date

June 14, 2019

Study Completion Date

June 14, 2019

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Bexagliflozin

20 mg, tablet

DRUG

Placebo for Bexagliflozin

inactive tablet to match active comparator bexagliflozin

DRUG

Glimepiride

2, 4 or 6 mg, capsule

DRUG

Placebo for Glimepiride

inactive capsules to match active comparator glimepiride

Trial Locations (45)

21073

Research Site 2, Hamburg

22607

Research Site, Hamburg

28467

Research Site, Calabash

28557

Research Site, Morehead City

32806

Research Site, Orlando

33012

Research Site, Hialeah

33016

Research Site, Miami Lakes

33401

Research Site, West Palm Beach

35205

Research Site, Birmingham

39120

Research Site, Magdeburg

45277

Research Site, Essen

45355

Research Site 2, Essen

63739

Research Site, Aschaffenburg

69115

Research Site, Heidelberg

77355

Research Site, Magnolia

88239

Research Site, Wangen

90057

Research Site, Los Angeles

90255

Research Site, Huntington Park

94070

Research Site, San Carlos

32-700

Research Site, Bochnia

85-312

Research Site, Bydgoszcz

30-015

Research Site, Krakow

31-011

Research Site 2, Krakow

90-242

Research Site, Lodz

20-064

Research Site 2, Lublin

20-362

Research Site, Lublin

10-117

Research Site, Olsztyn

61-655

Research Site, Poznan

24-100

Research Site, Puławy

28-200

Research Site, Staszów

62-020

Research Site, Swarzędz

21-040

Research Site, Świdnik

87-100

Research Site, Torun

00-660

Research Site, Warsaw

22-400

Research Site, Zamość

Unknown

Research Site, Alicante

Research Site 2, Barcelona

Research Site, Barcelona

Research Site 2, Madrid

Research Site 3, Madrid

Research Site, Madrid

Research Site 2, Málaga

Research Site, Málaga

Research Site 2, Oviedo

Research Site, Valencia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theracos

INDUSTRY

NCT02769481 - Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects | Biotech Hunter | Biotech Hunter